Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CBUS stock hub

Cibus, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CBUSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

109.8M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CBUS

In the news

Latest news · CBUS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-221

P25 -105.6P50 -46.5P75 -3.1

ROIC-13.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CBUS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

204

Groups with data

Currency

USD

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001705843
Company name	Cibus, Inc.
Country	United States
Country code	US
Cusip	17166A101
Employees	118
Employees Change	-41%
Employees Change Percent	-25.79
Enterprise value	$367.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2017-07-20
Isin	US17166A1016
Last refreshed	2026-05-10
Market cap	$109.8M
Market cap category	Micro-Cap
Price	$1.44
Price currency	USD
Rev Per Employee	30,838.98x
Sector	Healthcare
Sic	2870
Symbol	CBUS
Website	https://www.cibus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-115.69%
EV Sales Forward	46.33x
EV/Sales	101.1x
FCF yield	-46.58%
P/B ratio	3.58x
P/S ratio	30.19x
PS Forward	13.83x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$3.6M
Gross Profit Growth	-14.62%
Gross Profit Growth Q	-12.79%
Gross Profit Growth3 Y	185.12%
Net Income	$-127.1M
Net Income Growth Years	2%
Pretax Margin	-3,632.1%
Profit Per Employee	$-1.1M
ROA	-12.87
Roa5y	-24.12
ROCE	-23.41
ROE	-221
Roe5y	-163.7
ROIC	-13.53

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-42.42%
Cagr3y	-56.92%
Cagr5y	-63.33%
EPS Growth Years	2
Revenue Growth	-14.62x
Revenue Growth Q	-12.79x
Revenue Growth Years	0x
Revenue Growth3 Y	185.12x
Revenue Growth5 Y	-31.34x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$305M
Cash	$9.9M
Current Assets	$12.1M
Current Liabilities	$16.9M
Debt	$268M
Debt Equity	$12.28
Equity	$21.8M
Interest Coverage	-1.9
Liabilities	$283.2M
Long Term Assets	$293M
Long Term Liabilities	$266.4M
Net Cash	$-258M
Net Cash By Market Cap	$-235
Net Debt Equity	$11.82
Tangible Book Value	$-242.4M
Tangible Book Value Per Share	$-4.46
WACC	11.31

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.72
Net Working Capital	$-11.5M
Quick ratio	0.63
Working Capital	$-4.8M
Working Capital Turnover	$-0.94

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-97.04%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-42.4%
200-day SMA	1.8
3Y total return	-92.01%
50-day SMA	2.25
50-day SMA vs 200-day SMA	50over200
5Y total return	-99.34%
All Time High	1,594.5
All Time High Change	-99.91%
All Time High Date	2017-10-11
All Time Low	1.09
All Time Low Change	32.11%
All Time Low Date	2025-11-14
ATR	0.17
Beta	1.66
Beta1y	2.14
Beta2y	2.71
Ch YTD	-17.24
High	1.53
High52	4.19
High52 Date	2026-03-11
High52ch	-65.64%
Low	1.43
Low52	1.09
Low52 Date	2025-11-14
Low52ch	32.11%
Ma50ch	-35.94%
Price vs 200-day SMA	-20.18%
RSI	40.7
RSI Monthly	37.64
RSI Weekly	42.72
Sharpe ratio	0.09x
Sortino ratio	0.18
Total Return	-97.04%
Tr YTD	-17.24
Tr1m	-9.43%
Tr1w	-0.69%
Tr3m	-30.77%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	1
Analyst Price Target Top	$3
Analyst Ratings	Buy
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.16
Earnings Revenue Estimate	1,552,800x
Earnings Revenue Estimate Growth	50.17x
Operating Income	$-67.5M
Operating margin	-1,853.9
Price target	$9
Price Target Change	$525
Price Target Change Top	$108

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	57,200,585%
Float Percent	74.98%
Net Borrowing	-1,108,000
Shares Insiders	25%
Shares Institutions	24.76%
Shares Out	76,283,095
Shares Qo Q	0.43%
Shares Yo Y	97.04%
Short Float	7.18%
Short Ratio	4.87
Short Shares	5.38

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-59.4M
Average Volume	471,276.6x
Bv Per Share	0.4
CAPEX	$-578,000
Ch1m	-9.43
Ch1w	-0.69
Ch1y	-42.4
Ch3m	-30.77
Ch3y	-92.01
Ch5y	-99.34
Ch6m	9.92
Change	-4%
Change From Open	-4
Close	1.5
Days Gap	0
Depreciation Amortization	5,923,000
Dollar Volume	361,687.7
Earnings Date	2026-05-14
Earnings Time	amc
EBIT	$-67.5M
EBITDA	$-61.5M
EPS	$-2.78
F Score	2
FCF	$-51.2M
FCF EV Yield	-13.91x
FCF Per Share	$-0.67
Financing CF	46,648,000
Fiscal Year End	December
Founded	2,010
Goodwill	232,516,000
Income Tax	$29,000
Investing CF	-578,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-17
Last Report Date	2025-12-31
Last Split Date	2023-06-01
Last Split Type	Reverse
Last10k Filing Date	2026-03-17
Ma150	1.94
Ma150ch	-25.73%
Ma20	1.47
Ma20ch	-2.11%
Net CF	-4,510,000
Next Earnings Date	2026-05-14
Open	1.5
Optionable	Yes
Position In Range	10.53
Post Close	1.44
Postmarket Change Percent	10.76
Postmarket Price	$1.6
Ppne	27,857,000
Price Date	2026-05-08
Relative Volume	0.53x
Revenue	3,639,000x
SBC By Revenue	225.01x
Share Based Comp	8,188,000
Tax By Revenue	0.8x
Tr6m	9.92%
Us State	California
Volume	251,172
Z Score	-4.52

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CBUS pay a dividend?

Capital-return profile for this ticker.

Performance

CBUS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CBUS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+24.8%

Float: +75.0% of shares outstanding

Insider ownership

+25.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CBUS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.7

Neutral momentum band

Price vs 200-day MA

-20.2%

50/200-day relationship not available

Beta (5Y)

1.66

More volatile than the market

Sharpe ratio

0.09

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CBUS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CBUS stock rating?

Cibus, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CBUS analysis?

The full report lives at /stocks/CBUS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CBUS?

The latest report frames CBUS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CBUS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.